全体要約
関連する質問
20.1 Billion USD (2023)
16.2% (2024-2032)
Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc.
高齢者人口の増加、慢性疾患の有病率の上昇、液体生検の普及
概要
目次
Description
Table of Contents